Inspire Investing LLC Invests $772,000 in Transcat, Inc. (NASDAQ:TRNS)

Inspire Investing LLC acquired a new position in shares of Transcat, Inc. (NASDAQ:TRNS) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 6,454 shares of the scientific and technical instruments company’s stock, valued at approximately $772,000. Inspire Investing LLC owned about 0.07% of Transcat at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Charles Schwab Investment Management Inc. increased its stake in shares of Transcat by 14.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 68,339 shares of the scientific and technical instruments company’s stock worth $7,472,000 after purchasing an additional 8,857 shares during the last quarter. Wasatch Advisors LP increased its stake in shares of Transcat by 13.3% during the 4th quarter. Wasatch Advisors LP now owns 701,099 shares of the scientific and technical instruments company’s stock worth $76,651,000 after purchasing an additional 82,458 shares during the last quarter. Quadrature Capital Ltd acquired a new position in shares of Transcat during the 1st quarter worth about $619,000. Calamos Advisors LLC increased its stake in shares of Transcat by 76.0% during the 2nd quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company’s stock worth $1,848,000 after purchasing an additional 6,667 shares during the last quarter. Finally, First Horizon Advisors Inc. increased its stake in shares of Transcat by 26.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock worth $72,000 after purchasing an additional 125 shares during the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Stock Performance

Shares of TRNS opened at $128.02 on Friday. Transcat, Inc. has a 52 week low of $84.45 and a 52 week high of $147.12. The firm has a market cap of $1.17 billion, a P/E ratio of 80.52 and a beta of 0.67. The firm’s 50-day simple moving average is $124.55 and its 200 day simple moving average is $119.56.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Monday, July 29th. The scientific and technical instruments company reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.20. The firm had revenue of $66.70 million during the quarter, compared to the consensus estimate of $69.35 million. Transcat had a net margin of 5.69% and a return on equity of 8.48%. The business’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.38 EPS. As a group, equities analysts forecast that Transcat, Inc. will post 2.06 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. HC Wainwright reiterated a “buy” rating and issued a $156.00 price target on shares of Transcat in a research note on Tuesday, July 30th. Craig Hallum decreased their price target on shares of Transcat from $150.00 to $138.00 and set a “buy” rating on the stock in a research note on Wednesday, July 31st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $151.33.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.